Luca Incrocci
Overview
Explore the profile of Luca Incrocci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
3010
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikitas J, Jamshidian P, Tree A, Hall E, Dearnaley D, Michalski J, et al.
Lancet Oncol
. 2025 Feb;
26(3):378-386.
PMID: 39894025
Background: The association between acute and late toxicity following prostate radiotherapy has not been well studied using data from multiple randomised clinical trials and fractionation schedules. We aimed to characterise...
2.
Brand V, Milder M, Christianen M, de Vries K, Hoogeman M, Incrocci L, et al.
Adv Radiat Oncol
. 2025 Jan;
10(2):101701.
PMID: 39866592
Purpose: Ultrahypofractionation presents challenges for a subset of high-risk prostate cancer patients due to the large planning target volume (PTV) margin required for the seminal vesicles. Online adaptive radiation therapy...
3.
Jongen C, Heemsbergen W, Incrocci L, Heijmen B, Rossi L
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766106
Background/objectives: Extracting spatial features (texture analysis) from dose distributions (dosiomics) for outcome prediction is a rapidly evolving field in radiotherapy. To account for fraction size differences, the biological effective dose...
4.
Jongen C, Heijmen B, Schillemans W, Zolnay A, Witte M, Pos F, et al.
Clin Transl Radiat Oncol
. 2025 Jan;
50:100886.
PMID: 39763489
Purpose: To develop a single NTCP model for grade ≥ 2 late rectal bleeding (G2 LRB) after conventional or hypofractionated radiotherapy for prostate cancer. Methods And Materials: The development dataset...
5.
Sinzabakira F, Heemsbergen W, Mugenzi P, Ndoli A, Maniragaba T, Umubyeyi C, et al.
JCO Glob Oncol
. 2024 Dec;
10:e2400311.
PMID: 39705635
Purpose: Moderate hypofractionation (MHF) offers logistical and financial advantages, and has become standard in Western countries but not yet in Africa. This study assessed GI and genitourinary (GU) acute toxicity...
6.
van Genderingen J, Nguyen D, Knuth F, Nomer H, Incrocci L, Sharfo A, et al.
Radiother Oncol
. 2024 Dec;
203():110662.
PMID: 39647528
Background And Purpose: Fast, high-quality deep learning (DL) prediction of patient-specific 3D dose distributions can enable instantaneous treatment planning (IP), in which the treating physician can evaluate the dose and...
7.
Jahreiss M, Heemsbergen W, Aben K, Incrocci L
Transl Androl Urol
. 2024 Aug;
13(7):1288-1296.
PMID: 39100827
This review investigates the complex landscape of secondary bladder cancer (SBC) after radiotherapy for prostate cancer (PCa). External beam radiotherapy (EBRT) poses an increased risk for SBC, while brachytherapy seems...
8.
van Hoogstraten L, Kiemeney L, Meijer R, van Leenders G, Vanneste B, Incrocci L, et al.
Bladder Cancer
. 2024 Jul;
8(2):139-154.
PMID: 38993368
Background: The COVID-19 pandemic has disrupted regular health care with potential consequences for non-COVID diseases like cancer. To ensure continuity of oncological care, guidelines were temporarily adapted. Objective: To evaluate...
9.
Jahreiss M, Incrocci L, Aben K, de Vries K, Hoogeman M, Hooning M, et al.
Acta Oncol
. 2024 Jul;
63:511-517.
PMID: 38946286
Purpose: In evaluating second primary cancers (SPCs) following External Beam Radiotherapy (EBRT), the role of lifestyle factors is frequently not considered due to data limitations. We investigated the association between...
10.
de Jong F, Ifle I, van der Made A, Kooper D, de Jong J, Franckena M, et al.
Eur Urol Open Sci
. 2024 Mar;
62:131-139.
PMID: 38496820
Background: Patients with muscle-invasive bladder cancer (MIBC) who receive radiotherapy with curative intent are followed by imaging, cystoscopy, and urine cytology. However, interpretation of cytology and cystoscopy is hampered by...